Literature DB >> 7869103

The CNS-specific hyaluronan-binding protein BEHAB is expressed in ventricular zones coincident with gliogenesis.

D M Jaworski1, G M Kelly, S Hockfield.   

Abstract

Hyaluronan (HA) is a ubiquitous component of extracellular matrices, and in several systems it plays a central role in regulating cellular proliferation and differentiation. Cell, or tissue,-specific functions of HA are likely to be mediated by cell, or tissue,-specific HA-binding proteins. We previously hyaluronan-binding protein from rat and cat (Jaworski et al., 1994). In view of the potential role of HA in neural differentiation, we examined the expression of BEHAB during late embryonic and early postnatal development of the rat. BEHAB is expressed at very high levels in ventricular zones throughout the neuraxis. Expression is first detected at embryonic day 15 (E15) in the spinal cord, and is detected at progressively more rostral levels at later ages. BEHAB expression, like other features of neural development, follows both caudal-to-rostral and ventral-to-dorsal gradients. The timing of BEHAB expression parallels the timing of the generation of glial cells. In all areas of the CNS examined, BEHAB expression begins after the peak of neurogenesis and coincident with gliogenesis. The regulation of proliferation and differentiation by HA in other tissues, together with the expression of BEHAB in zones of mitotic activity coincident with the generation of glia, suggests that the extracellular matrix protein encoded by BEHAB could play a role in the generation or differentiation of CNS glia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869103      PMCID: PMC6577851     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  12 in total

Review 1.  Physiology of angiogenesis.

Authors:  H Kurz
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 2.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons.

Authors:  H Yamada; B Fredette; K Shitara; K Hagihara; R Miura; B Ranscht; W B Stallcup; Y Yamaguchi
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Aggrecan is expressed by embryonic brain glia and regulates astrocyte development.

Authors:  Miriam S Domowicz; Timothy A Sanders; Clifton W Ragsdale; Nancy B Schwartz
Journal:  Dev Biol       Date:  2008-01-22       Impact factor: 3.582

5.  Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo.

Authors:  H Zhang; G Kelly; C Zerillo; D M Jaworski; S Hockfield
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

Review 6.  Proteoglycans in brain development.

Authors:  Nancy B Schwartz; Miriam Domowicz
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Astrocyte precursor response to embryonic brain injury.

Authors:  Miriam S Domowicz; Judith G Henry; Natasha Wadlington; Antonia Navarro; Richard P Kraig; Nancy B Schwartz
Journal:  Brain Res       Date:  2011-03-09       Impact factor: 3.252

8.  Brevican knockdown reduces late-stage glioma tumor aggressiveness.

Authors:  Chrissa A Dwyer; Wenya Linda Bi; Mariano S Viapiano; Russell T Matthews
Journal:  J Neurooncol       Date:  2014-07-23       Impact factor: 4.130

9.  Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas.

Authors:  Hosung Sim; Bin Hu; Mariano S Viapiano
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

10.  Gsx transcription factors control neuronal versus glial specification in ventricular zone progenitors of the mouse lateral ganglionic eminence.

Authors:  Heather Chapman; Amy Riesenberg; Lisa A Ehrman; Vikram Kohli; Diana Nardini; Masato Nakafuku; Kenneth Campbell; Ronald R Waclaw
Journal:  Dev Biol       Date:  2018-07-07       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.